We are pleased to announce the 2nd Annual European HealthTech CEO Forum (Digital & MedTech), which will take place on the 8th - 9th of March 2021 and be part of the DigitalSachs Spring Life Sciences Week, the latter will also incorporate the 14th Annual European Life Sciences CEO Forum.
Due to the pandemic, Sachs Zurich events will be hosted in a digital format for the first time. This will allow us to further support our community and past attendees. We will provide both the usual stimulating program and networking opportunities through our online video and audio meeting system.
The main programme for the 2nd Annual EHTF is spread throughout 2 days (8th-9th of March) and will include HealthTech Innovation Day, focusing on Investment & Partnership in MedTech and Digital Health, and Pandemic Response Day, focusing on new developments in tackling pandemic. The programme will feature topical keynotes and panels with industry leaders as well as over 20 corporate presentations by public, private and growth companies, plus over 20 pitches by seed companies. We anticipate 300+ delegates, including major and growth corporates, financial investors/partners, bankers and advisors.
Meetings will take place from the 8th to 12th of March. Moreover, the system will be open for 12 hours a day and we expect 1500+ meetings completed over 5 days. The conference will be held in the Central European Time Zone. The digital event will consist of:
HealthTech Innovation Day (Monday, 8th of March)
Digital Healthcare in the New Era of COVID-19 Panel
Digital Pharma & Drug Discovery Panel
MedTech & Device BD and Investment Panel
Revolutionising Hospital Care: New Technologies Panel
Innovation in Care Technology Panel
Innovation & Early Stage Investment Roundtable
Pandemic Response Day (Tuesday, 9th of March)
The Global Supply Chain in the Time of COVID-19 Panel
Overview of Vaccine Development & Roll Out Panel
The Challenges of Developing a Vaccine for an Emerging Country Vaccine Manufacturer
Advanced Therapeutics Panel
Diagnostics: New Technologies Panel
Patient Care in the Time of the Pandemic Panel
Networking Days (10th - 12th of March)
Confirmed Keynote Speakers Include:
Introductory Speech by Jeffrey Cohen, Managing Director, Equity Research, Ladenburg Thalmann & Co. Inc.
“Blitzscaling” atoms vs bytes: Key learnings from pandemic response by Mark Stevenson, Executive Vice President & Chief Operating Officer, Thermo Fisher Scientific
"Vaccine Rollout Put in Israel and Global Lessons" by Prof. Ran Balicer, MD, PhD, MPh, Chief Innovation Officer, Clalit Health Services
Fireside Chat with Sean Marett, Chief Business Officer & Chief Commercial Officer, BioNTech SE, moderated by Mike Ward, Global Head of Thought Leadership, Life Sciences and Healthcare, Clarivate
Confirmed Speakers Include:
Alex Zhavoronkov, Founder & CEO, Insilico Medicine, Inc.
Alexandra Vallon-Eberhard, Sr. Director Global BD, Roche Diagnostics
Amir Jafri, Founder & CEO, Immunicom, Inc.*
André Heeg, Managing Director & Partner, BCG Digital Ventures
Andreas Neubert, Chief Scientific Officer, IDT Biologika GmbH
Arild Kristensen, CEO, Norwegian Smart Care Cluster (NSCC)
Axel Nemetz, Independent
Beat Merz, Managing Director, New Harbor Venture Partners, LLC
Christoph Pedain, Head of Point of Care Diagnostics, Siemens Healthineers AG
Daniel O’Mahony, Partner, Seroba Life Sciences
Daniel Vitt, President & CEO, Immunic Therapeutics
David Cole, Leader EMEA, IBM Watson Health
David Gordon, Head of Investments, Longliv Ventures
Diana Saraceni, Co-Founder & General Partner, Panakès Partners SGR SpA
Dominik Pförringer, Academic Director of Venture Lab Healthcare, TU Munich
Elena Bonfiglioli, Managing Director Health and Life Sciences, EMEA, Microsoft Corporation
Eyal Zimlichman, Deputy Director General, CMO and CIO, Sheba Medical Center
Florian Schödel, Owner, Philimmune, LLC
Gilead Raday, COO, RedHill Biopharma Ltd.
Guy Spigelman, EMEA Lead, Healthcare & Life Sciences Startups, Amazon Web Services
Free access to view live sessions is provided to all interested and qualified participants. This will allow us to increase the size of the audience and provide a higher exposure for participating companies. Additionally, you can purchase a Video on Demand pass, which will allow you to view not only live sessions, but also recordings of all sessions, in addition to speaker and company profiles and their presentations.
The Online Meeting System will open on the 22nd of February for uploading profiles and sending meeting invites. Meetings will take place from the 8th to 12th of March. System will allow you to have a secure audio/video call, as well as option to present slides using screen share function. Meetings will last for 30 minutes. Basic Online Meeting System Access with 10 meeting invitations will be provided complimentary for qualified institutional (buy/sell-side), private equity and venture investors. The number of passes is limited, and priority is given to regular participants, however organizer has the discretion to reject passes. Other participants may consider purchasing Basic, Advanced and Premium Access with an option for a live spotlight or a pre-recorded showcase presentation. The number of meeting invites defines how many requests can be sent. If meeting invite is declined, you will receive an invite credit back that can be reused. The number of invites does not restrict how many meeting invitations you can receive.
Gain additional exposure to high-level decision makers by presenting at the forum, which offers excellent opportunities to showcase your company’s investment and partnering offering. This typically include technology and financial highlights. This adds to the news flow from the forum and generates greater interest in meetings from other delegates.
For those interested to join the companies’ showcases, there is an option to purchase either a 10 or 20 minute presentation, which will be pre-recorded in advance and available to all registered attendees before, during and after the conference on the event’s portal. There are also a limited number of 20-min Spotlight presentations with additional branding to provide even higher exposure, which will be broadcasted live during the main programme after relevant panel discussion and available on demand afterwards. Start-up companies, which are looking for seed financing may also apply for a 5 or 10 minute showcase option. The Sachs team can assist with the pre-recording of the presentation or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at Sachs Spring Life Sciences Week is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.
The virtual exhibition package includes a dedicated virtual page, where we can: upload your branded company’s profile and list ways to reach you; share video or images about services you provide; have files ready for download, if you wish to share any additional information with potential clients.
There are a limited number of sponsorship opportunities for the forum, which includes speaking, advertising and branding options. Sponsors typically include investment banks and funds, large pharma, technology companies and service providers, including Stock Exchanges, IR companies, CROs, international lawyers and consulting companies. Tailored packages are available upon request. You can view latest event’s sponsors here.
To learn more about presenting, exhibition or sponsorship opportunities, please contact us at SachsTeam@SachsForum.com or by phone + 44 (0)203 463 4890.
FINANCIAL, ADVISORY, INVESTORS ATTENDING:
3B Future Health Ventures Sarl (Helsinn Investment Fund) 3E Bioventures Additio Investment Group Advent Life Sciences Aisling Capital LLC Aqua Partners LLC ARCH Venture Partners Asabys Partners Asklepios Advisors ATEM Capital LLC Atlas Advisors LLC BCG Digital Ventures Bci Bergmann zur Hausen & Cie. GmbH BERNINA BioInvest Ltd. Bioscience Managers Biotech Alliances International, Inc. Biotechnology Business Institute Bootstrap Europe Boston Scientific Breslin AG BRESLIN AG & LSFA Brothers & Partners Europe Bryan, Garnier & Co. GmbH BTIG, LLC Capricorn Partners NV Cederberg GmbH Claris Ventures Clavis Capital Ltd. Crosswave Management, Inc. Curam Capital Management LLP DeBere Capital Partners Digital Networks Plc. S.r.l. Dorset Capital LLC Draper Esprit Earlybird Venture Capital Eaton Square EIT Health Investor Network European Investment Fund Fraser Finance LLP Fund+ Genextra S.p.A. Global Founders Capital GmbH Global Investment Bridge AG Global Neurohealth Ventures GLSV GmbH Good Health Capital LLC GreenSky Capital GrowthCube Partners LLC Guoqian VC H.C. Wainwright H.C. Wainwright & Co., LLC Health Passion Fund High-Tech Gründerfonds Management GmbH i&i Prague s.r.o. ICF Consult Switzerland Illumina Ventures Indaco Venture Partners SGR SpA Industrifonden INKEF Capital BV Inserm Transfert Initiative/Sofimac IPF Partners Kreos Capital Ladenburg Thalmann & Co. Inc. Landmark Angels, Inc./ Family Office Lauxera Capital Partners LBBW Venture Capital LifeCare Partners AG LionBird (Ventures) Ltd. Longliv Ventures Longwall Venture Partners LLP LSP (Life Sciences Partners) Lundbeckfonden Ventures MedPro Investors LLC Mid Atlantic Bio Angels Momentum Biotech Moonday Capital New Harbor Venture Partners, LLC Novo Holdings A/S NSIP LLC O2H Ventures Ltd. Optum Ventures Pacific Channel Limited Panacea Venture Panakès Partners SGR SpA Pathena Peppermint VenturePartners GmbH Peregrine Ventures Pitango Venture Capital PMV NV Portugal Capital Ventures - Sociedade de Capital de Risco, S.A. Redalpine Venture Partners AG Remiges Ventures RYSE Asset Management Salus Partners SA Sanan Capital Sandhill Angels SBI JI Innovation Advisory Ltd. Seroba Life Sciences Sofinnova Partners Stifel Financial Corp. Tandem Ventures Srl The Fulford Group Ltd. The Global Emerging Markets (GEM) Group Tribeca Companies Truffle Capital TruVenturo GmbH TVM Capital Life Science Venture Capital TVM Life Science Management GmbH Ventac Partners Vesalius Biocapital VI Partners AG Viopas Partners Vista Capital Advisors, LLC Viva BioInnovator Wellington Partners Wellington Partners Venture Capital XOventure GmbH Zühlke Ventures AG